GRI Bio annual return on equity
2024
2025
GRI Bio Return on Equity (ROE) Growth & History (GRI)
GRI Bio's return on equity was −238.17% for fiscal 2025.
View full GRI Bio company overviewGRI Bio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −238.17% | +144.35 pp |
| 2024 | 2024-12-31 | −382.52% | — |
GRI Bio quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −15.78% | +111.96 pp |
| Q1 2026 | 2026-03-31 | −24.14% | +92.19 pp |
| Q4 2025 | 2025-12-31 | −66.47% | −15.84 pp |
| Q3 2025 | 2025-09-30 | −126.37% | −75.70 pp |
| Q2 2025 | 2025-06-30 | −127.74% | −67.87 pp |
| Q1 2025 | 2025-03-31 | −116.33% | +7.13 pp |
| Q4 2024 | 2024-12-31 | −50.62% | +110.60 pp |
| Q3 2024 | 2024-09-30 | −50.67% | +17.55 pp |
| Q2 2024 | 2024-06-30 | −59.86% | +1609.94 pp |
| Q1 2024 | 2024-03-31 | −123.45% | — |
| Q4 2023 | 2023-12-31 | −161.22% | — |
| Q3 2023 | 2023-09-30 | −68.22% | — |
| Q2 2023 | 2023-06-30 | −1,669.80% | — |
| Q4 2021 | 2021-12-31 | −159.55% | — |
| Q3 2021 | 2021-09-30 | −13.53% | — |
| Q2 2021 | 2021-06-30 | −21.13% | — |
| Q1 2021 | 2021-03-31 | −49.90% | — |
GRI Bio return on equity trends
Between the periods ended 2024-12-31 and 2025-12-31, GRI Bio's return on equity increased from −382.52% to −238.17%, a change of +144.35 percentage points. The latest reported quarter, Q2 2026, shows −15.78%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GRI Bio source filings ↗